Literature DB >> 16529391

The GOAL study.

Anthony Durzo1.   

Abstract

Year:  2006        PMID： 16529391      PMCID： PMC1479721     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  4 in total

1.  Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial.

Authors:  P M O'Byrne; P J Barnes; R Rodriguez-Roisin; E Runnerstrom; T Sandstrom; K Svensson; A Tattersfield
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

2.  Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

Authors:  R A Pauwels; C G Löfdahl; D S Postma; A E Tattersfield; P O'Byrne; P J Barnes; A Ullman
Journal:  N Engl J Med       Date:  1997-11-13       Impact factor: 91.245

3.  Adult Asthma Consensus Guidelines update 2003.

Authors:  Catherine Lemière; Tony Bai; Meyer Balter; Charles Bayliff; Allan Becker; Louis-Philippe Boulet; Dennis Bowie; André Cartier; Andrew Cave; Kenneth Chapman; Robert Cowie; Stephen Coyle; Donald Cockcroft; Francine M Ducharme; Pierre Ernst; Shelagh Finlayson; J Mark FitzGerald; Frederick E Hargreave; Donna Hogg; Alan Kaplan; Harold Kim; Cheryle Kelm; Paul O'Byrne; Malcolm Sears; Andrea White Markham
Journal:  Can Respir J       Date:  2004 May-Jun       Impact factor: 2.409

4.  Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.

Authors:  Tom C Fardon; Daniel K C Lee; Kay Haggart; Lesley C McFarlane; Brian J Lipworth
Journal:  Am J Respir Crit Care Med       Date:  2004-06-07       Impact factor: 21.405
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.